DE60005164D1 - Verwendung von fucosilierten sialilierten n-acetyl-lactosamin-kohlenhydratstrukturen zur hemmung der bakteriellen adhäsion - Google Patents

Verwendung von fucosilierten sialilierten n-acetyl-lactosamin-kohlenhydratstrukturen zur hemmung der bakteriellen adhäsion

Info

Publication number
DE60005164D1
DE60005164D1 DE60005164T DE60005164T DE60005164D1 DE 60005164 D1 DE60005164 D1 DE 60005164D1 DE 60005164 T DE60005164 T DE 60005164T DE 60005164 T DE60005164 T DE 60005164T DE 60005164 D1 DE60005164 D1 DE 60005164D1
Authority
DE
Germany
Prior art keywords
sialyl
fucosilized
sialilated
lewis
bacterial adhesion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60005164T
Other languages
English (en)
Inventor
Thomas Boren
Lennart Hammarstroem
Karl-Anders Karlsson
Susann Teneberg
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Application granted granted Critical
Publication of DE60005164D1 publication Critical patent/DE60005164D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2896—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against molecules with a "CD"-designation, not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE60005164T 1999-03-19 2000-03-16 Verwendung von fucosilierten sialilierten n-acetyl-lactosamin-kohlenhydratstrukturen zur hemmung der bakteriellen adhäsion Expired - Lifetime DE60005164D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9901007A SE9901007D0 (sv) 1999-03-19 1999-03-19 Use of fucosylated sialylated N-acetyl lactosamin carbohydrate structures for inhibition of bacterial adherence
PCT/SE2000/000514 WO2000056343A1 (en) 1999-03-19 2000-03-16 Use of fucosylated sialylated n-acetyl lactosamine carbohydrate structures for inhibition of bacterial adherence

Publications (1)

Publication Number Publication Date
DE60005164D1 true DE60005164D1 (de) 2003-10-16

Family

ID=20414923

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60005164T Expired - Lifetime DE60005164D1 (de) 1999-03-19 2000-03-16 Verwendung von fucosilierten sialilierten n-acetyl-lactosamin-kohlenhydratstrukturen zur hemmung der bakteriellen adhäsion

Country Status (7)

Country Link
EP (1) EP1169044B1 (de)
JP (1) JP2002539266A (de)
AT (1) ATE249227T1 (de)
AU (1) AU4155700A (de)
DE (1) DE60005164D1 (de)
SE (1) SE9901007D0 (de)
WO (1) WO2000056343A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002066502A1 (en) * 2001-02-21 2002-08-29 Boren Thomas Helicobacter pylori sialic acid binding adhesin, saba and saba - gene
EP1411952B1 (de) * 2001-06-29 2009-04-22 Glykos Finland Oy Verwendung mindestens einer glycoinhibitor-substanz gegen infektionskrankheiten
FI20011403A (fi) * 2001-06-29 2002-12-30 Carbion Oy Menetelmä ja koostumukset vatsan sairauksien hoitoon
JP2005532793A (ja) * 2002-04-22 2005-11-04 レコファーマ アーベー 微生物付着を阻害するための融合ポリペプチドおよび方法
FI20021989A0 (fi) * 2002-11-06 2002-11-06 Halina Miller-Podraza Korkean affiniteetin Helicobacter pylori-reseptorit ja niiden käyttö
EP2692740A1 (de) * 2012-07-30 2014-02-05 Le Centre National De La Recherche Scientifique Glycanzusammensetzungen, Verfahren zu deren Herstellung und deren Verwendungen als Arzneimittel

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK76193D0 (da) * 1993-06-25 1993-06-25 Astra Ab Kulhydratderivater
WO1995023605A1 (en) * 1994-03-02 1995-09-08 Neose Pharmaceuticals, Inc. Method for treating and inhibiting gastric and duodenal ulcers

Also Published As

Publication number Publication date
AU4155700A (en) 2000-10-09
JP2002539266A (ja) 2002-11-19
ATE249227T1 (de) 2003-09-15
EP1169044B1 (de) 2003-09-10
WO2000056343A1 (en) 2000-09-28
EP1169044A1 (de) 2002-01-09
SE9901007D0 (sv) 1999-03-19

Similar Documents

Publication Publication Date Title
NO20024011L (no) Karbohydratformulering (prebiotisk hjelpemiddel) for å forbedre immunforsvaret
MXPA05000880A (es) Probioticos para funciones neuromusculares del intestino.
BR0013814A (pt) Métodos de tratamentos de um paciente humano suscetìvel a ou diagnosticado com uma doença com anticorpos anti-erbb2, artigos industrializados, métodos de tratamentos de câncer em pacientes humanos e usos do anticorpo anti-erbb2
CA2460749A1 (en) Glycoconjugate vaccines for use in immune-compromised populations
EP3326634A3 (de) Zusammensetzung zur anregung der darmflora in neugeborenen, die durch kayserschnitt geboren wurden
BR9911076A (pt) Uso de peg-ifn-alfa e ribavirina para o tratamento de hepatite c crÈnica
BR0206689A (pt) Combinação de probióticos, e, uso desta
NO20060498L (no) Metode for a promotere benvekst
ES2195866T3 (es) Composiciones acidas multiusos.
BR0112685A (pt) Composição nutricional
EA200701519A1 (ru) Живая аттенуированная ротавирусная вакцина для перорального введения
Stege et al. Antimicrobial activity of aqueous extracts of Larrea divaricata Cav (jarilla) against Helicobacter pylori
BR0314511A (pt) Seleção e uso de bactérias de ácido lático para reduzir a inflamação causada por helicobater
BRPI0016231B8 (pt) composições compreendendo enzimas úteis para tratar ou melhorar os riscos de infecção do trato digestivo
SE9600716D0 (sv) Adhesion inhibitors, preparation comprising them and method for producing them
BRPI0410341A (pt) conjugados de polissacarìdeo-proteìna derivatizados de meningococos multivalente e vacina
MX2008001520A (es) Composiciones de tizanidina y metodos de tratamiento usando las composiciones.
IL173481A0 (en) Polysaccharide double-layer microcapsules as carriers for biologically active substance oral administration
EP1393734A4 (de) Arzneimittel gegen darmerkrankungen
DE60005164D1 (de) Verwendung von fucosilierten sialilierten n-acetyl-lactosamin-kohlenhydratstrukturen zur hemmung der bakteriellen adhäsion
SE9904581D0 (sv) A novel helicobacter pylori-binding substance and use thereof
BRPI0410761A (pt) uso de leucina, e, composição para administração entérica a pacientes
BRPI0416088A (pt) composição, sistema, e método de tratar condições tais como calcificação vascular
Robo et al. HBOT application at cases of gingival inflammation
Isler Doxycycline-induced esopageal ulceration

Legal Events

Date Code Title Description
8332 No legal effect for de